We analyzed through array CGH the genomic profile of 47 biopsies, from hereditary breast cancer patients, 40 from BRCAX patients, 3 from BRCA1 and 4 from BRCA2 mutation carriers (Table 1). This evidence concerns the gene BRCA1 and breast carcinoma.